Welch & Forbes’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $391K | Hold |
2,057
| – | – | ﹤0.01% | 315 |
|
|
2026
Q1 | $347K | Hold |
2,057
| – | – | ﹤0.01% | 311 |
|
|
2025
Q4 | $347K | Hold |
2,057
| – | – | ﹤0.01% | 309 |
|
|
2025
Q3 | $297K | Hold |
2,057
| – | – | ﹤0.01% | 331 |
|
|
2025
Q2 | $260K | Sell |
2,057
-50
| -2% | -$6.14K | ﹤0.01% | 342 |
|
|
2025
Q1 | $269K | Hold |
2,107
| – | – | ﹤0.01% | 329 |
|
|
2024
Q4 | $279K | Hold |
2,107
| – | – | ﹤0.01% | 336 |
|
|
2024
Q3 | $307K | Hold |
2,107
| – | – | ﹤0.01% | 333 |
|
|
2024
Q2 | $293K | Sell |
2,107
-75
| -3% | -$10K | ﹤0.01% | 329 |
|
|
2024
Q1 | $299K | Hold |
2,182
| – | – | ﹤0.01% | 335 |
|
|
2023
Q4 | $296K | Sell |
2,182
-50
| -2% | -$6.1K | ﹤0.01% | 332 |
|
|
2023
Q3 | $273K | Hold |
2,232
| – | – | ﹤0.01% | 336 |
|
|
2023
Q2 | $283K | Sell |
2,232
-25
| -1% | -$3.25K | ﹤0.01% | 336 |
|
|
2023
Q1 | $292K | Hold |
2,257
| – | – | ﹤0.01% | 330 |
|
|
2022
Q4 | $296K | Hold |
2,257
| – | – | 0.01% | 330 |
|
|
2022
Q3 | $264K | Hold |
2,257
| – | – | 0.01% | 339 |
|
|
2022
Q2 | $265K | Sell |
2,257
-50
| -2% | -$5.93K | ﹤0.01% | 345 |
|
|
2022
Q1 | $301K | Hold |
2,307
| – | – | ﹤0.01% | 335 |
|
|
2021
Q4 | $352K | Hold |
2,307
| – | – | 0.01% | 326 |
|
|
2021
Q3 | $373K | Hold |
2,307
| – | – | 0.01% | 316 |
|
|
2021
Q2 | $378K | Hold |
2,307
| – | – | 0.01% | 319 |
|
|
2021
Q1 | $347K | Buy |
2,307
+87
| +4% | +$13.8K | 0.01% | 325 |
|
|
2020
Q4 | $336K | Hold |
2,220
| – | – | 0.01% | 322 |
|
|
2020
Q3 | $301K | Hold |
2,220
| – | – | 0.01% | 305 |
|
|
2020
Q2 | $303K | Hold |
2,220
| – | – | 0.01% | 297 |
|
|
2020
Q1 | $239K | Hold |
2,220
| – | – | 0.01% | 299 |
|
|
2019
Q4 | $268K | Hold |
2,220
| – | – | 0.01% | 317 |
|
|
2019
Q3 | $221K | Hold |
2,220
| – | – | 0.01% | 336 |
|
|
2019
Q2 | $242K | Hold |
2,220
| – | – | 0.01% | 317 |
|
|
2019
Q1 | $248K | Hold |
2,220
| – | – | 0.01% | 319 |
|
|
2018
Q4 | $214K | Hold |
2,220
| – | – | 0.01% | 320 |
|
|
2018
Q3 | $271K | Hold |
2,220
| – | – | 0.01% | 319 |
|
|
2018
Q2 | $244K | Hold |
2,220
| – | – | 0.01% | 327 |
|
|
2018
Q1 | $237K | Hold |
2,220
| – | – | 0.01% | 328 |
|
|
2017
Q4 | $237K | Hold |
2,220
| – | – | 0.01% | 317 |
|
|
2017
Q3 | $247K | Hold |
2,220
| – | – | 0.01% | 307 |
|
|
2017
Q2 | $229K | Buy |
+2,220
| New | +$219K | 0.01% | 324 |
|
|
2014
Q4 | – | Sell |
-2,400
| Closed | -$219K | – | 349 |
|
|
2014
Q3 | $219K | Hold |
2,400
| – | – | 0.01% | 325 |
|
|
2014
Q2 | $206K | Buy |
+2,400
| New | +$189K | 0.01% | 322 |
|
Other funds holding IBB
CB
Welch & Forbes's IBB Position: Q2 2026 in Review
Welch & Forbes held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 2,057 shares worth $391K. The position accounts for ﹤0.01% of the portfolio, ranked #315.
Welch & Forbes first reported a position in IBB in Q2 2014 and has held it in 39 quarters since. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- Welch & Forbes held 2,057 shares of iShares Biotechnology ETF worth $391K as of Q2 2026.
- Welch & Forbes left its iShares Biotechnology ETF share count unchanged in Q2 2026.
- iShares Biotechnology ETF made up ﹤0.01% of Welch & Forbes's portfolio in Q2 2026, its #315 holding.
- Welch & Forbes first reported a position in iShares Biotechnology ETF in Q2 2014 and has held it in 39 quarters since.
- 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on Welch & Forbes's 13F filing for Q2 2026, filed 30 Jul 2026.